We connect strategy, evidence, accountability, and execution across the functions that move an asset through the clinic.
Clinical, regulatory, CMC, safety, quality, data, and commercial teams each bring a valid perspective to the program. The leadership challenge is turning those perspectives into one coherent path while evidence is still developing.
When assumptions remain implicit, trade-offs are revisited, or decision ownership is unclear, teams lose time reopening questions. We make assumptions, trade-offs, dependencies, and decision rights visible then translate them into repeatable governance and planning processes.
Scimitar helps make assumptions, trade-offs, dependencies, and decision rights visible, then translates them into governance, ways of working, and executable plans.
Turn portfolio intent into an executable asset path.
You are balancing scientific potential, patient need, investment, timing, and organizational capacity across an evolving portfolio.
The challenge is making the trade-offs visible enough for teams to act without pretending the uncertainty has disappeared.
Make regulatory strategy usable across the program.
You are influencing pathways, agency interactions, submissions, and the conditions under which the asset can advance.
The challenge is translating the strategy into decisions and requirements other functions can act on early.
Bring product and process decisions into the asset strategy early.
Formulation, analytical methods, control strategy, scale-up, supply, and technical change evolve alongside the clinical program.
The challenge is making CMC implications visible before program decisions become expensive to revisit.
Build an evidence plan the organization can execute.
Protocol choices connect to patient access, sites, vendors, data, regulatory expectations, supply, and cost.
The challenge is bringing operational reality into the strategy early enough to protect both the evidence and the timeline.
Create the decision cadence that keeps the program moving.
You work across functions, milestones, risk, governance bodies, and competing priorities.
The challenge is creating enough structure for timely decisions and accountability without adding process that slows the work.
Build quality and risk into the plan while choices are still open.
You help teams identify what matters most to patient safety, data integrity, and evidence reliability.
The challenge is making quality part of development judgment rather than a review performed after the strategy has already hardened.
Make data usable when the program needs to decide.
You are responsible for turning complex and fragmented evidence into something leaders can interpret and trust.
The challenge is connecting data standards, systems, analysis, and human judgement to the decisions that move the asset.
Transfer knowledge and accountability without losing momentum.
You are bringing together organizations with different systems, incentives, terminology, and decision structures.
The challenge is preserving critical knowledge while creating one practical way of working across organizational boundaries.
Scimitar helps development teams turn strategy into decisions the program can act on. We work across clinical, regulatory, CMC, quality, data, and commercial interfaces to clarify assumptions, trade-offs, ownership, and execution, then stay through implementation so the organization can sustain the approach.
Scimitar works alongside asset and portfolio leaders, clinical development, regulatory, CMC development, development operations and program management, R&D quality, data and biometrics, and alliance and integration leaders.
Scimitar makes the basis of a decision visible: the assumptions behind the plan, the trade-offs between options, the functions affected by each choice, and what would justify revisiting it later. Teams work from a shared reference point instead of reopening the same questions every time the program meets.
Yes. Scimitar helps organizations define decision rights, escalation paths, meeting cadence, and the information each governance body needs in order to decide. The objective is enough structure to keep decisions moving without adding unnecessary process.
Yes. Scimitar helps teams connect the clinical, regulatory, CMC, supply, and commercial elements of a development plan so that dependencies and timing consequences are visible while the choices are still open.
Scimitar does not stop at recommendations. We work alongside the people accountable for the program, integrate process, technology, and human capital, and stay involved through implementation and ownership transfer. The goal is a capability the organization can run without us.
Scimitar starts with the development problem rather than the technology. We look for practical ways to make existing knowledge more usable, improve how information reaches a decision, and reduce manual effort. Any AI-enabled approach is designed around the workflow, data, governance, controls, regulatory expectations, human judgement, and adoption required to make it sustainable.
When programs revisit decisions, discover dependencies late, or struggle to turn strategy into coordinated action, we identify what blocks them and implement a practical operating approach with the people who will own it.
Explore the capabilities we bring across process, technology, and people to improve development execution.
, icon={}, image={}, link={url={type=EXTERNAL, content_id=null, href=, href_with_scheme=}, open_in_new_tab=false, no_follow=false, sponsored=false, user_generated_content=false, rel=}}Explore the capabilities we bring across process, technology, and people to improve development execution.
